Pedram Heidari obtained his Ph.D. from Tehran University of Medical Sciences in 2008. He is an assistant professor of radiology at Harvard Medical School and the director of clinical research at the Division of Nuclear Medicine and Molecular Imaging at Massachusetts General Hospital. His research interests include dosimetry, immuno-oncology, novel pet radiopharmaceuticals, psma, radiopharmaceutical therapies, receptors, somatostatin, and theranostics.
Pedram Heidari obtained his Ph.D. from Tehran University of Medical Sciences in 2008. He is an assistant professor of radiology at Harvard Medical School and the director of clinical research at the Division of Nuclear Medicine and Molecular Imaging at Massachusetts General Hospital. His research interests include dosimetry, immuno-oncology, novel pet radiopharmaceuticals, psma, radiopharmaceutical therapies, receptors, somatostatin, and theranostics.